| Value | ₹17.33 Cr |
|---|
NSE filing, NSE: IBLFL. Summary written from the filing by ALFA Finder's alert engine.
IBL Finance Ltd: key numbers
- Share price
- ₹61.60
- Market cap
- ₹152.3 Cr
- Revenue (annual)
- ₹17.14 Cr
- Net profit (annual)
- ₹2.44 Cr
- P/E (TTM)
- 62.4×Sector 19.1×
- Promoter holding
- 63.18%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from IBL Finance Ltd
All →IBL Finance Debt & Borrowing: ₹50 Cr
IBL Finance withdrew its ₹50 crore NCD issue on October 22, 2026 after failing to meet minimum subscription. BSE approved the withdrawal due to operational challenges.
- Value
- ₹50.00 Cr
IBL Finance Debt & Borrowing
IBL Finance Limited has decided to withdraw its ongoing public issue of Non-Convertible Debentures due to operational and technical challenges within the banking infrastructure.
IBL Finance Business Update
IBL Finance Limited announced a milestone, having cumulatively disbursed loans worth ₹478.04 crore to over 2.61 lakh customers across India.
IBL Finance Debt & Borrowing: ₹50 Cr
IBL Finance Limited's Finance Committee approved the prospectus for a public issue of non-convertible debentures, aggregating up to ₹50 Crore.
- Value
- ₹50.00 Cr
IBL Finance Q1 FY27 Results: Net Profit ₹0.4 Cr, Up 0.0% YoY
IBL Finance Ltd reported revenue from operations of ₹4.5 Cr (+9.8% YoY) and net profit of ₹0.4 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.4 Cr · +0.0% YoY
IBL Finance Debt & Borrowing
IBL Finance Limited has allotted non-convertible debt securities. The post-allotment paid-up capital remains unchanged from the pre-allotment figure of Rs. 24.73 Crore.
Other financial results announcements
All →Glittek Granites Q2 FY27 Results: Turns Profitable, Net Profit ₹0.1 Cr
Glittek Granites Ltd reported revenue from operations of ₹0.3 Cr and net profit of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net profit ₹0.1 Cr
Sudarshan Pharma Industries Q2 FY27 Results: Net Profit ₹8.1 Cr, Up 92.9% YoY
Sudarshan Pharma Industries Ltd reported revenue from operations of ₹217 Cr (+28.5% YoY) and net profit of ₹8.1 Cr (+92.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹8.1 Cr · +92.9% YoY
STL Networks Q2 FY27 Results: Net Loss of ₹16.1 Cr, Loss Narrows
STL Networks Ltd reported revenue from operations of ₹270.1 Cr (+17.0% YoY) and a net loss of ₹16.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹16.1 Cr
RPG Life Sciences Q2 FY27 Results: Net Profit ₹28.2 Cr, Down 23.6% YoY
RPG Life Sciences Ltd reported revenue from operations of ₹211.6 Cr (+16.5% YoY) and net profit of ₹28.2 Cr (-23.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹28.2 Cr · -23.6% YoY
Alldigi Tech Q2 FY27 Results: Net Profit ₹26.6 Cr, Up 51.1% YoY
Alldigi Tech Ltd reported revenue from operations of ₹153.3 Cr (+4.0% YoY) and net profit of ₹26.6 Cr (+51.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹26.6 Cr · +51.1% YoY
Krishna Defence and Allied Industries Q2 FY27 Results: Net Profit ₹1,532 Cr, Up 71.8% YoY
Krishna Defence and Allied Industries Ltd reported revenue from operations of ₹7,529 Cr (+55.7% YoY) and net profit of ₹1,532 Cr (+71.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,532 Cr · +71.8% YoY